IGC Pharma, Inc.

NYSEAM:IGC Stock Report

Market Cap: US$28.6m

IGC Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:IGC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Sep 24BuyUS$200,000James MoranIndividual588,235US$0.34

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IGC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,404,7369.56%
Institutions16,627,15521.5%
General Public53,417,48369%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.5%.

Top Shareholders

Top 25 shareholders own 31.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.9%
Bradbury Fund Management Limited
13,823,529US$5.1m-21.6%no data
5.62%
Ram Mukunda
4,353,417US$1.6m23.5%no data
1.35%
Richard Prins
1,042,917US$385.4k-16.1%no data
1.34%
Claudia Grimaldi
1,037,000US$383.2k0%no data
1.22%
James Moran
942,402US$348.2k166%no data
0.91%
BlackRock, Inc.
703,798US$260.1k0%no data
0.83%
The Vanguard Group, Inc.
645,166US$238.4k0%no data
0.73%
Geode Capital Management, LLC
562,969US$208.0k31%no data
0.21%
State Street Global Advisors, Inc.
165,307US$61.1k0%no data
0.16%
Virtu Financial LLC, Asset Management Arm
123,060US$45.5k165%no data
0.15%
Dearborn Partners L.L.C.
116,401US$43.0k0%no data
0.13%
FullCircle Wealth LLC
103,443US$38.2k0%0.02%
0.13%
Two Sigma Securities, LLC, Asset Management Arm
99,017US$36.6k195%no data
0.092%
Northern Trust Global Investments
71,027US$26.2k0%no data
0.085%
Goldman Sachs Group, Investment Banking and Securities Investments
65,541US$24.2k0.07%no data
0.058%
Commonwealth Equity Services, LLC
44,600US$16.5k28.9%no data
0.047%
BB&T Trust
36,667US$13.5k0%no data
0.037%
Terry Lierman
29,000US$10.7k0%no data
0.028%
Group One Trading LP, Asset Management Arm
21,409US$7.9k-3.2%no data
0.023%
Morgan Stanley, Investment Banking and Brokerage Investments
17,757US$6.6k1,960%no data
0.014%
Baader Bank AG, Asset Management Arm
10,533US$3.9k0%no data
0.014%
Tower Research Capital Europe Limited
10,496US$3.9k30.9%no data
0.0039%
Geneos Wealth Management, Inc., Asset Management Arm
3,000US$1.1k0%no data
0.0013%
Simplex Trading, LLC, Asset Management Arm
1,012US$374.9-49.7%no data
0.0012%
Osaic Wealth, Inc. , Asset Management Arm
925US$340.515.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:03
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IGC Pharma, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Edward WooAscendiant Capital Markets LLC
Aditya KhandekarRedChip Companies, Inc.